Targeting the Assembly of the Human Immunodeficiency Virus Type I

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|10|30|3725-3739

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.10, Iss.30, 2004-11, pp. : 3725-3739

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting frameshifting in the human immunodeficiency virus

By Brakier-Gingras Léa   Charbonneau Johanie   Butcher Samuel E  

Expert Opinion on Therapeutic Targets, Vol. 16, Iss. 3, 2012-03 ,pp. : 249-258

Informa Healthcare

Access to resources Recommend Favorite

Targeting Strategies for Human Immunodeficiency Virus: A Combinatorial Approach

By  

Mini Reviews in Medicinal Chemistry, Vol. 12, Iss. 3, 2012-03 ,pp. : 236-254

Bentham Science Publishers

Access to resources Recommend Favorite

Use of Virostatics as a Means of Targeting Human Immunodeficiency Virus Infection

By  

Current Pharmaceutical Design, Vol. 12, Iss. 9, 2006-03 ,pp. : 1121-1127

Bentham Science Publishers

Access to resources Recommend Favorite

Dimerization of Human Immunodeficiency Virus Type 1 Reverse Transcriptase as an Antiviral Target

By  

Current Pharmaceutical Design, Vol. 12, Iss. 15, 2006-05 ,pp. : 1879-1894

Bentham Science Publishers

Access to resources Recommend Favorite

Nucleoside Inhibitors of Human Immunodeficiency Virus Type 1 Reverse Transcriptase

By  

Current Topics in Medicinal Chemistry, Vol. 4, Iss. 9, 2004-05 ,pp. : 895-919

Bentham Science Publishers

Access to resources Recommend Favorite